Alternate Text DC Chemicals' products qualify for U.S. tariff exemptions. We guarantee no price increases due to customs duties and maintain stable supply, continuing to deliver reliable research solutions to our American clients.

JNJ-67569762

  Cat. No.:  DC47721   Featured
Chemical Structure
2380313-26-6
For research use only. We do not sell to patients.
We match the best price and quality on market.
Email:order@dcchemicals.com  sales@dcchemicals.com
Tel:+86-021-58447131
We are official vendor of:
  • 20
  • 19
  • 18
  • 17
  • 16
  • 15
  • 14
  • 12
  • 11
  • 10
  • 9
  • 8
  • 13
  • 6
  • 5
  • 4
  • 3
  • 2
  • 1
More than 5000 active chemicals with high quality for research!
Field of application
JNJ-67569762 is a tetrahydropyridine-based BACE1 inhibitor targeting the S3 pocket with IC50 of 2.7 nM and shows 71-fold selectivity over BACE2.
Cas No.: 2380313-26-6
Chemical Name: JNJ-67569762
Synonyms: 1,3-Dioxolo[4,5-c]pyridine-6-carboxamide, N-[3-[(2S,5R)-6-amino-5-(ethylsulfonyl)-2-(fluoromethyl)-2,3,4,5-tetrahydro-5-methyl-2-pyridinyl]-4-fluorophenyl]-2,2-difluoro-;JNJ-67569762
SMILES: C1=NC(C(NC2=CC=C(F)C([C@@]3(CF)N=C(N)[C@@](S(CC)(=O)=O)(C)CC3)=C2)=O)=CC2OC(F)(F)OC1=2
Formula: C22H22F4N4O5S
M.Wt: 530.49249792099
Purity: >98%
Sotrage: 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO
MSDS
TITLE DOWNLOAD
MSDS_31571_DC47721_2380313-26-6
COA
LOT NO. DOWNLOAD
Cat. No. Product name Field of application
DC47721 JNJ-67569762 JNJ-67569762 is a tetrahydropyridine-based BACE1 inhibitor targeting the S3 pocket with IC50 of 2.7 nM and shows 71-fold selectivity over BACE2.
DC9901 Verubecestat (MK-8931) MK-8931 is a BACE1 inhibitor. MK-8931 binds significantly to β-secretase.
DC5053 LY2886721 LY2886721 is an BACE inhibitor used for the treatment of Alzheimer's Disease.
DC5180 LY2811376 LY2811376 is the first orally available non-peptidicβ-secretase(BACE1) inhibitor with IC50 of 239 nM-249 nM.
DC11551 Elenbecestat Elenbecestat (E2609) is a novel potent, oral BACE1 inhibitor for treatment of Alzheimer's disease..
DC11105 Umibecestat beta-secretase inhibitor.
DC8400 AZD3839 AZD3839 is a potent and selective BACE1 inhibitor with Ki of 26.1 nM, about 14-fold selectivity over BACE2. Phase 1.
X